Suppr超能文献

主动脉瘤中的NADPH氧化酶

NADPH Oxidases in Aortic Aneurysms.

作者信息

Salmon Morgan

机构信息

Department of Cardiac Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Antioxidants (Basel). 2022 Sep 16;11(9):1830. doi: 10.3390/antiox11091830.

Abstract

Abdominal aortic aneurysms (AAAs) are a progressive dilation of the infrarenal aorta and are characterized by inflammatory cell infiltration, smooth muscle cell migration and proliferation, and degradation of the extracellular matrix. Oxidative stress and the production of reactive oxygen species (ROS) have been shown to play roles in inflammatory cell infiltration, and smooth muscle cell migration and apoptosis in AAAs. In this review, we discuss the principles of nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase/NOX) signaling and activation. We also discuss the effects of some of the major mediators of NOX signaling in AAAs. Separately, we also discuss the influence of genetic or pharmacologic inhibitors of NADPH oxidases on experimental pre-clinical AAAs. Experimental evidence suggests that NADPH oxidases may be a promising future therapeutic target for developing pharmacologic treatment strategies for halting AAA progression or rupture prevention in the management of clinical AAAs.

摘要

腹主动脉瘤(AAAs)是肾下腹主动脉的渐进性扩张,其特征为炎症细胞浸润、平滑肌细胞迁移和增殖以及细胞外基质降解。氧化应激和活性氧(ROS)的产生已被证明在腹主动脉瘤的炎症细胞浸润、平滑肌细胞迁移和凋亡中起作用。在本综述中,我们讨论了烟酰胺腺嘌呤二核苷酸磷酸氧化酶(NADPH氧化酶/NOX)信号传导和激活的原理。我们还讨论了NOX信号传导的一些主要介质在腹主动脉瘤中的作用。另外,我们还讨论了NADPH氧化酶的基因或药物抑制剂对实验性临床前腹主动脉瘤的影响。实验证据表明,NADPH氧化酶可能是未来开发药物治疗策略以阻止腹主动脉瘤进展或预防临床腹主动脉瘤破裂的一个有前景的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3a5/9495752/cebcf5ba78d6/antioxidants-11-01830-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验